Evidence map›Paper›PMID 31468114›Full record

ArticleVirchows Archiv : an international journal of pathology2020

Prognostic impact of intra-field heterogeneity in oral squamous cell carcinoma.

Andrea Gabusi, Davide Bartolomeo Gissi, Lucio Montebugnoli, Sofia Asioli, Achille Tarsitano, Claudio Marchetti, Tiziana Balbi, Timothy R Helliwell, Maria P Foschini, Luca Morandi

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Development of head and neck pathology in Europe.Virchows Archiv : an international journal of pathology · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Andrea GabusiSection of Oral Science, Department of Biomedical and Neuromuscular Sciences, University of Bologna, Bologna, Italy.
Davide Bartolomeo GissiSection of Oral Science, Department of Biomedical and Neuromuscular Sciences, University of Bologna, Bologna, Italy.
Lucio MontebugnoliSection of Oral Science, Department of Biomedical and Neuromuscular Sciences, University of Bologna, Bologna, Italy.
Sofia AsioliDepartment of Biomedical and Neuromotor Sciences, "M. Malpighi" Section of Anatomic Pathology, Bellaria Hospital, via Altura 3, 40139, Bologna, Italy.
Achille TarsitanoUnit of Maxillofacial Surgery, S. Orsola Hospital, Bologna, Italy.
Claudio MarchettiUnit of Maxillofacial Surgery, S. Orsola Hospital, Bologna, Italy.
Tiziana BalbiUnit of Anatomic Pathology, S. Orsola Hospital, Bologna, Italy.
Timothy R HelliwellDepartment of Cellular Pathology, Royal Liverpool University Hospital, Liverpool, UK.
Maria P FoschiniDepartment of Biomedical and Neuromotor Sciences, "M. Malpighi" Section of Anatomic Pathology, Bellaria Hospital, via Altura 3, 40139, Bologna, Italy.
Luca MorandiDepartment of Biomedical and Neuromotor Sciences, "M. Malpighi" Section of Anatomic Pathology, Bellaria Hospital, via Altura 3, 40139, Bologna, Italy. luca.morandi2@unibo.it.ORCID http://orcid.org/0000-0002-3810-9760
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITOspedale Bellaria · ITUniversity of Bologna · ITUniversity of Liverpool · GB

Funding

Università di Bologna AlmaIdea2017
6 · The paper itself

Abstract

Genetic heterogeneity displayed by tumour cells (intratumoural heterogeneity, ITH) represents a diagnostic challenge when assessing tumour mutational profile. In oral squamous cell carcinoma (OSCC), ITH may be found both in tumour cells and in adjacent mucosa. Genetic heterogeneity of the adjacent mucosa can be interpreted as evidence of the field cancerization (field heterogeneity, FH). The aim of the study was to investigate the impact of intratumoural and intrafield heterogeneity on locoregional control. Ten OSCC patients (5 recurrent and 5 nonrecurrent) were studied. Multiple areas were sampled from the bulk of the tumour and the adjacent nonneoplastic mucosa. A panel of 10 tumour-specific OSCC driver genes was analysed for each sample and was used to calculate heterogeneity. Values were compared among recurrent and nonrecurrent OSCC. Mutational analysis highlighted that a single tumour sample has limited accuracy in assessing the genetic profiles of tumours. High values of ITH considering shared mutations between specimens were found in both recurrent and non-recurrent OSCC (p = 0.095). On the contrary, the intrafield genetic heterogeneity was significantly less frequently in the non-recurrent OSCC group (p = 0.032). Heterogeneity within each specimen calculated with variant allele frequency confirmed that there was better discrimination between recurrent and nonrecurrent groups using nonneoplastic adjacent mucosa than tumour tissue (p value 0.0006 and 0.0048 respectively). In agreement with the theory of field cancerization, intrafield genetic heterogeneity correlates with a higher risk of developing loco-regional recurrences and second primaries. In order to reduce the ITH effects, analysis of multiple tumour areas should be encouraged.

Indexed as

AdultAgedCarcinoma, Squamous CellFemaleGenetic HeterogeneityHumansMaleMiddle AgedMouth NeoplasmsMutationNeoplasm Recurrence, LocalPrognosisField cancerizationIntratumoural heterogeneityOral squamous cell carcinomaPrognosis

Identifiers

PMID31468114
OpenAlexW2970294817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.